-
- Apr 15, 2021
Rheumatoid arthritis associated-ILD may reduce life expectancy
Rheumatoid arthritis (RA) in combination with interstitial lung disease (RA-ILD) may reduce life expectancy despite a downward trend in mortality of RA and RA-ILD over the last 20 years, according to a study.
Researchers utilized data from death certificates over a 20-year span to analyze mortality…
-
- Apr 13, 2021
Understanding of radiation oncology in sarcoma improved with...
A novel virtual educational program for medical students improved perceived knowledge of radiation o... -
- Apr 13, 2021
Thyroid eye disease biomarkers provide potential information...
A regulatory pathway of biomarkers for thyroid eye disease (TED) was constructed by researchers to h...
VIDEOS
- Mar 16, 2021
Clinical Trials for Alagille Syndrome | NIDDK
-
Mar 16, 2021
NORD Video: Alagille Syndrome
-
Mar 15, 2021
Understanding the Clinical Impact…
-
Mar 12, 2021
Treatment Challenges in Lupus…
-
Mar 12, 2021
Practice Pearls: Lupus Nephritis
-
Jan 10, 2021
Biomarkers for pediatric lupus…
-
Jan 10, 2021
The Pathology of Lupus Nephritis…
-
Uncommon Interstitial Lung Diseases -- BAVLS
Nov 19, 2020
-
Interstitial Lung Disease with Dr. Sally Suliman
Nov 19, 2020
-
Emerging Therapies for Interstitial Lung Disease
Nov 19, 2020
Conference Roundup
- Apr 13, 2021
Investigational therapy improves overall survival in metastatic uveal melanoma
Tebentafusp (IMCgp100; Immunocore) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) as a first-line treatment in patients with metastatic uveal melanoma, according to Phase 3 clinical trial results presented at…
-
-
-
AMX0035 lower long-term risk of death in ALS
Mar 23, 2021
-
Continuing Medical Education
-
NORD: Giant Cell (Session 1)
Mar 23, 2020
-
-
NORD: Spinal Muscular Atrophy
Mar 23, 2020
-
NORD: Pediatric Epilepsy
Mar 23, 2020
Journal Scan
- Apr 15, 2021
Rheumatoid arthritis associated-ILD may reduce life expectancy
Rheumatoid arthritis (RA) in combination with interstitial lung disease (RA-ILD) may reduce life expectancy despite a downward trend in mortality of RA and RA-ILD over the last 20 years, according to a study.
…
-
-
-
What is ‘Quiet’ Thyroid Eye Disease?
Apr 08, 2021
-
Trending Topics
- Apr 09, 2021
Adjuvant pembrolizumab improves disease-free survival in renal cell carcinoma
Pembrolizumab (Keytruda; Merck) improved disease-free survival (DFS) compared with placebo in patients with renal cell carcinoma (RCC) following nephrectomy or following nephrectomy and resection of metastatic lesions, according to data from the pivotal Phase 3 KEYNOTE-564 trial…
Resources
-
Tools
- Find Zebra
- Genetic and Rare Diseases Information Center
- National Organization for Rare Disorders (NORD)
- National Organization for Rare Disorders (NORD): Patient Assistance Programs
- NCATS Toolkit for Patient-Focused Therapy Development
- NCCN Guidelines
- NORD Online Physician Guides
- Orphan Products Clinical Trials Grants Program
- Orphanet
- Rare Diseases Registry Program
-
Patient Tools
- testing post